on February 3, 2003
Published online before print February 3, 2003, doi: 10.1161/01.CIR.0000051364.70064.D1
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 28, 2002
From the Division of Cardiology (B.R.K., N.V., G.P., F. Mulhaupt, F. Mach), Division of Endocrinology and Diabetes, Department of Medicine (R.W.J.), and Department of Pediatrics (M.C.), University Hospital, Geneva, Switzerland. * To whom correspondence should be addressed. E-mail: francois.mach{at}medecine.unige.ch.
Background--Gap junctions allow the direct exchange of ions and small molecules between cells in contact, thus coordinating physiological processes such as cell growth and differentiation. We have recently demonstrated increased expression of the gap junction protein connexin43 (Cx43) in specific subsets of cells in atherosclerotic lesions. Because the development of atherosclerosis depends critically on paracrine cell-to-cell interactions, we hypothesized that direct intercellular communication via gap junctions may be another factor controlling atherogenesis. Methods and Results--The role of Cx43 in atherogenesis was examined by use of both a genetic and a pharmacological approach. First, atherosclerosis-susceptible LDL receptor-deficient (LDLR-/-) mice with normal (Cx43+/+) or reduced (Cx43+/-) levels of Cx43 were fed a cholesterol-rich diet for 14 weeks. The progression of atherosclerosis was reduced by 50% (P<0.01) in the thoracoabdominal aorta and in the aortic roots of Cx43+/-LDLR-/- mice compared with Cx43+/+LDLR-/- controls. Atheroma in Cx43+/-LDLR-/- mice contained fewer inflammatory cells and exhibited thicker fibrous caps with more collagen and smooth muscle cells. Next, we observed that HMG-CoA reductase inhibitors, or "statins," lipid-lowering drugs well known for their pleiotropic antiatherogenic effects, reduced Cx43 expression in primary human vascular cells in vitro. Atheroma of LDLR-/- mice treated orally with pravastatin contained fewer inflammatory cells and exhibited thicker fibrous caps than controls. This was associated with reduced Cx43 expression in lesions of statin-treated mice. Conclusions--These data indicate a critical role for Cx43-mediated gap junctional communication in atherosclerotic plaque formation.
Revised on November 7, 2002
Accepted on November 11, 2002
Reduced Connexin43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor-Deficient Mice
Brenda R. Kwak PhD,
Key words: atherosclerosis • ion channels • drugs
This article has been cited by other articles:
 |
|
 |
|
  S. R. Johnstone, J. Ross, M. J. Rizzo, A. C. Straub, P. D. Lampe, N. Leitinger, and B. E. Isakson Oxidized Phospholipid Species Promote in Vivo Differential Cx43 Phosphorylation and Vascular Smooth Muscle Cell Proliferation Am. J. Pathol., August 1, 2009; 175(2): 916 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Berliner, N. Leitinger, and S. Tsimikas The role of oxidized phospholipids in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S207 - S212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-F. Li and S. Roy High Glucose-Induced Downregulation of Connexin 43 Expression Promotes Apoptosis in Microvascular Endothelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1400 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Burnier, P. Fontana, A. Angelillo-Scherrer, and B. R. Kwak Intercellular Communication in Atherosclerosis Physiology, February 1, 2009; 24(1): 36 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Veliz, F. G. Gonzalez, B. R. Duling, J. C. Saez, and M. P. Boric Functional role of gap junctions in cytokine-induced leukocyte adhesion to endothelium in vivo Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1056 - H1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Chadjichristos, S. Morel, J.-P. Derouette, E. Sutter, I. Roth, A. C. Brisset, M.-L. Bochaton-Piallat, and B. R. Kwak Targeting Connexin 43 Prevents Platelet-Derived Growth Factor-BB-Induced Phenotypic Change in Porcine Coronary Artery Smooth Muscle Cells Circ. Res., March 28, 2008; 102(6): 653 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Galkina and K. Ley Vascular Adhesion Molecules in Atherosclerosis Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2292 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Zadelaar, R. Kleemann, L. Verschuren, J. de Vries-Van der Weij, J. van der Hoorn, H. M. Princen, and T. Kooistra Mouse Models for Atherosclerosis and Pharmaceutical Modifiers Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1706 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liao, C. P. Regan, I. Manabe, G. K. Owens, K. H. Day, D. N. Damon, and B. R. Duling Smooth Muscle-Targeted Knockout of Connexin43 Enhances Neointimal Formation in Response to Vascular Injury Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1037 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Chadjichristos, C. M. Matter, I. Roth, E. Sutter, G. Pelli, T. F. Luscher, M. Chanson, and B. R. Kwak Reduced Connexin43 Expression Limits Neointima Formation After Balloon Distension Injury in Hypercholesterolemic Mice Circulation, June 20, 2006; 113(24): 2835 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Isakson, D. N. Damon, K. H. Day, Y. Liao, and B. R. Duling Connexin40 and connexin43 in mouse aortic endothelium: evidence for coordinated regulation Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1199 - H1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Veillard, S. Steffens, G. Pelli, B. Lu, B. R. Kwak, C. Gerard, I. F. Charo, and F. Mach Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo Circulation, August 9, 2005; 112(6): 870 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Isakson and B. R. Duling Heterocellular Contact at the Myoendothelial Junction Influences Gap Junction Organization Circ. Res., July 8, 2005; 97(1): 44 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zhang, J. Cheng, G. Lam, D. K. Jin, L. Vincent, N. R. Hackett, S. Wang, L. M. Young, B. Hempstead, R. G. Crystal, et al. Adenovirus Vector E4 Gene Regulates Connexin 40 and 43 Expression in Endothelial Cells via PKA and PI3K Signal Pathways Circ. Res., May 13, 2005; 96(9): 950 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Wang, X. Zhu, Q. Xu, X. Ding, Y. E. Chen, and Q. Song Effect of C-reactive protein on gene expression in vascular endothelial cells Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1539 - H1545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Dai, M. R. Kaazempur-Mofrad, S. Natarajan, Y. Zhang, S. Vaughn, B. R. Blackman, R. D. Kamm, G. Garcia-Cardena, and M. A. Gimbrone Jr. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature PNAS, October 12, 2004; 101(41): 14871 - 14876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. F. Figueroa, B. E. Isakson, and B. R. Duling Connexins: Gaps in Our Knowledge of Vascular Function Physiology, October 1, 2004; 19(5): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ando, S. Tsuruoka, H. Yamamoto, T. Takamura, S. Kaneko, and A. Fujimura Effects of Pravastatin on the Expression of ATP-Binding Cassette Transporter A1 J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 420 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W Wong, T. Christen, and B. R Kwak Connexins in leukocytes: shuttling messages? Cardiovasc Res, May 1, 2004; 62(2): 357 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Veillard, B. Kwak, G. Pelli, F. Mulhaupt, R. W. James, A. E.I. Proudfoot, and F. Mach Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice Circ. Res., February 6, 2004; 94(2): 253 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Tulenko Regulating Cross-Talk Between Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, October 1, 2003; 23(10): 1707 - 1709. [Full Text] [PDF]
|
|